Revenue segments as reported by the company.

Pharmacy revenues

Premiums

Fees and other revenues

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Pharmacy and other service costs

Medical costs and other benefit expenses

Selling, general and administrative expenses

Amortization of acquired intangible assets

Special items

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cigna

Express Scripts is a company that provides integrated pharmacy benefit management services including network-pharmacy claims processing; home delivery pharmacy services; specialty pharmacy benefit management, through its subsidiary Accredo; benefit-design consultation; drug-utilization review; formulary management; and medical and drug data analysis services to manage drug plans for health plans, self-insured employers and government agencies (both as administrator of employee benefits and public assistance programs). Express Scripts also offers pharmacy benefit management services for workers' compensation insurance programs. The program is accredited by URAC, the nation's largest accrediting body for pharmacy benefit management companies. The company processes pharmaceutical claims for members through a network of retail pharmacies. Its own automated pharmacies dispense long-term, chronic medications-like those for diabetes or heart disease-directly to members by home delivery.

Express Scripts

The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cigna posts strong Q4 earnings, eyes growth in specialized services

Cigna delivered strong financial results in Q4 2022, with robust revenue growth and operational performance across key business segments.
While facing challenges such as margin pressures and potential disenrollment, Cigna is well-positioned to capitalize on growth opportunities in 2023.
Strategic partnerships, customer-focused strategies, and financial discipline underscore Cigna's commitment to sustainable growth and shareholder value creation.
Investments in innovation, care coordination, and market expansion signal a proactive approach to navigating industry dynamics and driving future success.

Cigna reports robust Q1 earnings, eyes growth amid challenges

Cigna's Q1 2023 showcased strong financials, growth in key segments, and increased outlook.
Challenges include economic softening impact and margin expectations for the year.
Opportunities lie in customer relationships, innovation, and market-specific strategies.
Overall, Cigna remains confident in delivering on its financial and growth targets.

Cigna reports robust Q2 results, eyes growth through innovation

Cigna's Q2 2023 performance was strong, with revenue growth, customer expansion, and technological advancements driving positive outcomes.
While facing challenges like disenrollment and risk adjustment payables, Cigna is leveraging strengths in technology and cross-selling for growth.
Opportunities lie in partnerships like VillageMD, continued innovation, and strategic bidding strategies for future growth.
Overall, Cigna remains confident in delivering on adjusted EPS outlook for 2023 and 2024, with a focus on innovation and growth.

Cigna surpasses Q3 expectations, eyes $28 EPS in 2024

Cigna's Q3 performance exceeded expectations, driven by strong revenue and EPS growth across key business segments.
Strategic focus on innovation, affordability, and client partnerships positions Cigna well for future growth and value creation.
Challenges in margin expectations and enrollment declines require proactive management and strategic decision-making.
Opportunities lie in continued growth projections, strategic investments, and enhancing healthcare affordability and accessibility.

Cigna reports robust Q4 performance, eyes growth amid strategic changes

Cigna Group's Q4 2023 Earnings Call highlighted strong financial performance, leadership changes, and strategic decisions. Analyst inquiries focused on growth drivers, market outlook, and internal healthcare spend management. The outlook for 2024 includes expectations of solid adjusted EPS, revenue growth, and operating cash flow.

Cigna surpasses Q1 expectations, eyes growth through AI and biosimilars

Cigna's Q1 performance exceeded expectations, driven by strong revenue and EPS figures.
Despite challenges like noncash losses and disruptions, Cigna's strategic strengths in AI, biosimilars, and value-based care position it well for growth.
Opportunities in AI-driven healthcare solutions, biosimilar expansions, and strategic M&A offer avenues for future growth.
Cigna's focus on precision care solutions and client outcomes showcases its commitment to innovation and efficiency.

Cigna (CI) posts robust Q2 results, eyes biosimilar growth

Cigna (CI) reports strong Q2 financial results driven by Evernorth Health Services and Express Scripts' innovative programs.
Focus on affordability, access, and behavioral health services propels growth in U.S. employer business.
Challenges include navigating healthcare cost pressures and ensuring fair pricing negotiations.
Opportunities lie in biosimilar growth, sustainable revenue outlook, and strategic Medicare Advantage business sale.

Cigna reports robust Q3 earnings, eyes growth opportunities in 2025

Cigna's Q3 earnings call highlighted strong financial performance, strategic focus on shareholder value, and challenges in specialty drugs and cost trends. The company is optimistic about opportunities in 2025 and remains committed to delivering shareholder value through strategic initiatives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Atmos Energy

Otter Tail

Proteostasis Therapeutics

TreeHouse Foods

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

Bet on Rising P/E With These 5 Top Stocks

Haemonetics

Horizon Pharma

Vertex Pharmaceuticals

BioXcel Therapeutics

With the third quarter of what has proven to be a remarkable 2020 coming to a close, many of the firms we cover across Wall Street already are looking to the stretch run of the year and at what should be an improving 2021 economy as we emerge from the COVID-19 pandemic restrictions.

5 Jefferies High-Conviction Health Care Stocks May Be Huge Q4 Winners

Analysts are telling investors to buy Cigna stock, but there are reasons to question the long-term future of the health insurer.
The post Why Evernorth May Not Resolve Cigna’s Long-Term Issues appeared first on InvestorPlace.

Why Evernorth May Not Resolve Cigna’s Long-Term Issues

Anthem

Centene

HCA Healthcare

Humana

Molina Healthcare

UnitedHealth Group

Health insurers and hospital stocks depreciate after Justice Ruth Bader Ginsburg who defended the Obamacare breathes her last.

Uncertainty Over Supreme Court Ruling Weighs on Healthcare

Cigna (CI) is poised for growth, given its continuous efforts to innovate solutions and growing suite of telehealth services.

Here's Why You Should Retain Cigna Stock in Your Portfolio

BLOOMFIELD, Conn., Sept. 16, 2020 /PRNewswire/ -- Cigna Corporation (NYSE: CI) announces the launch of Evernorth, a new brand for its growing, high-performing health services portfolio.

Cigna Launches Evernorth To Accelerate Delivery Of Innovative And Flexible Health Service Solutions

Cigna's (CI) health plans with enhanced features will not only expand its customer reach by 27% but also strengthen its presence on the individual exchange.

Cigna (CI) Enhances Offerings in the Individual Exchange

BLOOMFIELD, Conn., Sept. 9, 2020 /PRNewswire/ -- Cigna Corp, a global health service company, is enhancing its offerings to customers who access health coverage through the Affordable Care Act (ACA) marketplace, frequently referred to as the individual exchange.

Cigna Expands Offerings for Individuals - Increasing Access to Quality Care in More Communities Across the Country

Cigna will increase the number of counties it will offer individual coverage under the Affordable Care Act by 27% to more than 300 counties spanning 10 states next year.

Cigna Will Expand Obamacare To 300 Counties In 10 States For 2021

Bristol-Myers

Mercury General

Altria

Vectrus

VMware

As of last Wednesday, the stock market had literally never been better. Yet Thursday’s pullback (and the continued Friday sell-off) raise doubts about this rosy picture.

Top Value Stocks For September

CVS Health

CVS Health has gained roughly 17% since the March 23 lows of this year, while Cigna has fared much better and gained 39% over that same period. The health insurance companies have benefited in the current crisis due to lower medical costs and higher enrollments due to an increase in unemployment.

A Better Buy: CVS Health Or Cigna?

Cigna's (CI) collaboration with Dignity Health intends to provide improved health outcomes for the California and Nevada communities.

Cigna and Dignity Health Sign New Deal to Serve Patients

A Delaware judge’s ruling that neither Cigna nor Anthem can college damages in a battle over who sabotaged their mega-merger years ago means no breakup fees or billion-dollar payout for either health plan.

Not Even A $1B Breakup Fee For Cigna From Anthem Lawsuit

Despite a 36% rise since the March 23 lows of this year, at the current price of around $177 per share, we believe Cigna’s stock (NYSE: CI), a health insurance and pharmacy services management company, looks attractive and it could offer significant upside from the current levels.

Cigna Stock Looks Attractive At $180

Cigna (CI) reported earnings 30 days ago. What's next for the stock?

Cigna (CI) Up 1.5% Since Last Earnings Report: Can It Continue?

Cigna Corp. CI, -0.37% disclosed Thursday that it expects to affirm previously provided full-year financial guidance, when it meets with investors and analysts over the next several weeks.

Cigna affirms 2020 profit and revenue outlook, 2021 EPS target

Immunomedics

Medtronic

With earnings reporting for the second quarter all but over, and the summer starting to wind down, many of the top companies we follow on Wall Street are making some changes to the lists of their high-conviction stock picks for clients.

BofA Securities Adds Medical Technology Giant to the US 1 List

Cigna's (CI) prolific business profile creates a steady revenue recovery trajectory while its solid financial footing enables reinvestment in business

Cigna Banks on Diversified Business, Solid Capital Position

Cigna's (CI) Q2 earnings gain from a strong fundamental performance and reduced medical costs from delayed treatments amid the COVID-19 pandemic.

Cigna (CI) Earnings Surpass Estimates in Q2, Improve Y/Y

Cigna Corporation (CI) CEO David Cordani on Q2 2020 Results - Earnings Call Transcript

Cigna (CI) delivered earnings and revenue surprises of 15.05% and 4.11%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Cigna (CI) Q2 Earnings and Revenues Top Estimates

BLOOMFIELD, Conn., July 30, 2020 /PRNewswire/ -- Total revenues in the second quarter were $39.3 billion.

Cigna Expands Stakeholder and Community Support, Reports Second Quarter 2020 Performance

Cigna's (CI) business is likely to have been weighed down in Q2 due to high unemployment rate, partly offset by the delay in elective procedures resulting in lower claims.

Will Cigna (CI) Keep the Beat Streak Alive in Q2 Earnings?

Cigna (NYSE: CI) releases its next round of earnings this Thursday, July 30. Get the latest predictions in Benzinga's essential guide to the company's Q2 earnings report.

Earnings Preview for Cigna

CareDx

Teladoc

Companies across the healthcare sector experience a mixed impact from coronavirus. While some gain traction from a surge in virtual care, the rest suffers demand woes and supply-chain glitches.

News for Cigna Stock (CI)